Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03955055 · ClinicalTrials.gov registry record · NA

Study of Early Endocapsule (EC) in Clinical Decision Unit Versus Standard of Care Work-up for GI Bleeding

A NA study of Gastro Intestinal Bleeding and Hematemesis, sponsored by Christopher Marshall.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT03955055 is a NA study of Gastro Intestinal Bleeding and Hematemesis that has completed, run by Christopher Marshall. The registered enrollment target is 35 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03955055, a NA study of Gastro Intestinal Bleeding and Hematemesis, has completed, sponsored by Christopher Marshall.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the use of the Olympus EndoCapsule EC-10 video capsule compared with the standard of care workup for patients in the Clinical Decision Unit who have symptoms of gastrointestinal (GI) bleeding. Patients will be eligible if they have any symptoms of GI bleeding, either vomiting blood or symptoms without vomiting blood. Patients randomized to the early capsule arm will have an immediate video capsule endoscopy. Patients randomized to the standard of care arm will have no study intervention and will follow the treating physician's diagnostic workup. The primary goal of the study is to compare how often a source of bleeding is identified in patients in the two groups.

Interventions

  • DEVICE Video Capsule Endoscopy

Study Locations (1)

Massachusetts

  • UMass Memorial Medical Center - Worcester

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2020-02-04
Est. Completion 2022-04-09
Phase NA

Sponsor

Christopher Marshall

1 total trials

What the Registry Record Tells You About NCT03955055

The ClinicalTrials.gov registry entry for NCT03955055 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Christopher Marshall, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Gastro Intestinal Bleeding appearing as the primary indexed condition, and to 1 intervention - of which Video Capsule Endoscopy is the first listed.

NCT03955055 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03955055 about?

NCT03955055 is a clinical study titled "Study of Early Endocapsule (EC) in Clinical Decision Unit Versus Standard of Care Work-up for GI Bleeding". This study will evaluate the use of the Olympus EndoCapsule EC-10 video capsule compared with the standard of care workup for patients in the Clinical Decision Unit who have symptoms of gastrointestinal (GI) bleeding. Patients will be eligible if they have any symptoms of GI bleeding, either vomitin...

What is the current status of trial NCT03955055?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2020-02-04. Estimated completion is 2022-04-09.

What conditions does trial NCT03955055 study?

This clinical trial studies the following conditions: Gastro Intestinal Bleeding, Hematemesis, Melena.

What interventions are being tested in trial NCT03955055?

The interventions under investigation include: Video Capsule Endoscopy (DEVICE).

Who is sponsoring clinical trial NCT03955055?

This trial is sponsored by Christopher Marshall, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03955055 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.